Alexander Frank, MD
Family Medicine · Oklahoma City, OKNPI 1164450573
Payments from drug & device makers
Across 217 payments — averaging $14,242 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Skye Orthobiologics LLC$3.1M
- Johnson & Johnson$4K
- Acadia Pharmaceuticals Inc$1K
- Avanir Pharmaceuticals, Inc.$684
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$552
- Novartis$258
- plus $1K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Skye Orthobiologics LLC | 1 | $3,082,225 |
| Johnson & Johnson | 15 | $4,469 |
| Acadia Pharmaceuticals Inc | 24 | $1,157 |
| Avanir Pharmaceuticals, Inc. | 83 | $684 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 33 | $552 |
| Novartis | 15 | $258 |
| Corium, LLC | 5 | $187 |
| Gilead | 7 | $164 |
| Neurocrine Biosciences, Inc. | 1 | $136 |
| Sun Pharmaceutical Industries Inc. | 2 | $129 |
| Teva Pharmaceuticals USA, Inc. | 6 | $92 |
| Sunovion Pharmaceuticals Inc. | 4 | $77 |
| UCB, Inc. | 3 | $62 |
| Smith+Nephew | 3 | $52 |
| GSK | 2 | $36 |
| Indivior Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Sumitomo Pharma America, Inc. | 3 | $27 |
| Urovant Sciences Inc | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
How this compares
$3,090,489 in reported general payments places this provider in the 95th percentile of 1,730 family medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Oklahoma City
- Carl GriffinOklahoma City$28.2M
- Charles LunnOklahoma City$1.4M
- Hieu NguyenOklahoma City$238K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Brett CauthenOklahoma City$77K
- Angelique BarretoOklahoma City$74K
- John PittmanOklahoma City$39K
- Terrence TruongOklahoma City$32K
- Jonathon KnoxOklahoma City$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.